Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alen Marijam

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|January 22, 2018
Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model typesLaure-Anne Van Bellinghen, Alen Marijam, Gabriela Tannus Branco de Araujo, et al.
BMC Infectious Diseases|May 3, 2023
Unmet needs in uncomplicated urinary tract infection in the United States and Germany: a physician surveyMegan O'Brien, Alen Marijam, Fanny S Mitrani-Gold, et al.
Human Vaccines & Immunotherapeutics|October 14, 2025
Health and economic burden of herpes zoster in adults in Finland: A retrospective nationwide database studyMari Kanerva, Suvi E Heinonen, Tuukka Hakkarainen, et al.
Human Vaccines & Immunotherapeutics|March 8, 2022
Cost effectiveness and budget impact of universal varicella vaccination in RussiaAlen Marijam, Ekaterina Safonova, Mikhail Scherbakov, et al.
Infectious Diseases and Therapy|June 13, 2024
Treatment Patterns and Adherence to Guidelines for Uncomplicated Urinary Tract Infection in Germany: A Retrospective Cohort StudyAxel Krinner, Michael Schultze, Alen Marijam, et al.
Human Vaccines & Immunotherapeutics|December 12, 2022
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countriesAlen Marijam, Lode Schuerman, Patricia Izurieta, et al.
Human Vaccines & Immunotherapeutics|March 16, 2026
Costs of managing adverse reactions to hexavalent vaccines: Comparison of DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib in France and SpainGeorge Nikitas, Ahmed Mohy, Maurine Duchenne, et al.
Expert Review of Vaccines|July 28, 2025
Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in GermanyMaria Waize, Pavo Marijic, Alen Marijam, et al.
Vaccines|November 25, 2023
Knowledge, Attitudes, and Practices of European Healthcare Professionals towards Hepatitis A and Hepatitis B Vaccination in at-Risk AdultsDasha Shamarina, Martina Sluga-O'Callaghan, George Kassianos, et al.
Plos One|November 21, 2022
Treatment patterns, healthcare resource use, and costs associated with uncomplicated urinary tract infection among female patients in the United StatesRena C Moon, Alen Marijam, Fanny S Mitrani-Gold, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|January 22, 2018
Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model typesLaure-Anne Van Bellinghen, Alen Marijam, Gabriela Tannus Branco de Araujo, et al.
BMC Infectious Diseases|May 3, 2023
Unmet needs in uncomplicated urinary tract infection in the United States and Germany: a physician surveyMegan O'Brien, Alen Marijam, Fanny S Mitrani-Gold, et al.
Human Vaccines & Immunotherapeutics|October 14, 2025
Health and economic burden of herpes zoster in adults in Finland: A retrospective nationwide database studyMari Kanerva, Suvi E Heinonen, Tuukka Hakkarainen, et al.
Human Vaccines & Immunotherapeutics|March 8, 2022
Cost effectiveness and budget impact of universal varicella vaccination in RussiaAlen Marijam, Ekaterina Safonova, Mikhail Scherbakov, et al.
Infectious Diseases and Therapy|June 13, 2024
Treatment Patterns and Adherence to Guidelines for Uncomplicated Urinary Tract Infection in Germany: A Retrospective Cohort StudyAxel Krinner, Michael Schultze, Alen Marijam, et al.
Human Vaccines & Immunotherapeutics|December 12, 2022
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countriesAlen Marijam, Lode Schuerman, Patricia Izurieta, et al.
Human Vaccines & Immunotherapeutics|March 16, 2026
Costs of managing adverse reactions to hexavalent vaccines: Comparison of DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib in France and SpainGeorge Nikitas, Ahmed Mohy, Maurine Duchenne, et al.
Expert Review of Vaccines|July 28, 2025
Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in GermanyMaria Waize, Pavo Marijic, Alen Marijam, et al.
Vaccines|November 25, 2023
Knowledge, Attitudes, and Practices of European Healthcare Professionals towards Hepatitis A and Hepatitis B Vaccination in at-Risk AdultsDasha Shamarina, Martina Sluga-O'Callaghan, George Kassianos, et al.
Plos One|November 21, 2022
Treatment patterns, healthcare resource use, and costs associated with uncomplicated urinary tract infection among female patients in the United StatesRena C Moon, Alen Marijam, Fanny S Mitrani-Gold, et al.
Pageof 4